Dalia Argaman

Dalia Argaman has served in a variety of senior management positions in the medical device field. She also has vital experience in running international clinical trials in US, Europe and Japan and vast experience in submission and obtaining regulatory approvals, including FDA/ PMA and 510k Applications for Class ll and lll devices, CE and JPAL (Shonin) approvals. Prior to joining EarlySense, Ms. Argaman served as the Director of Clinical and Regulatory Affairs at Glucon Medical, developer of non-invasive glucose monitoring device as well as various other companies developing medical, therapeutic, and diagnostic and/or IVD devices. She holds a M.Sc. in Physical Chemistry from Tel Aviv University.

Dalia Argaman is the VP of Clinical and Regulatory Affairs at EarlySense, based in Asia. With a background in Biotechnology, Dalia Argaman has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.